Immunology
PD-1 receptor deficiency enhances CD30 - Nature
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout - Yahoo Finance
Sanofi to Buy Immunology Biotech Blueprint for $9.1 Billion - Bloomberg
Press Release: Sanofi to acquire Blueprint Medicines, - GlobeNewswire
Immune system discovery reveals potential solution to Alzheimer’s - EurekAlert!
Succinate undermines FOXP3 stability and disrupts T - Nature
Regulatory T cell therapies to treat autoimmune diseases and transplant rejection - Nature
Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch - Nature
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections - Nature
Immune System
How your pets alter your immune system - BBC
Immune system discovery reveals potential solution to Alzheimer’s - EurekAlert!
Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications - Nature
Vitamin C, anyone? The truth about ‘immunity boosters’ - The Times
Targeting viral enzymes to strengthen brain immunity against HSV-1 - Medical Xpress
AI used to design immune-safe 'zinc finger' proteins for gene therapy - Phys.org
Herpes virus protein boosts T cell power against cancer - Drug Target Review
Serotonergic neurons regulate the Drosophila vascular niche to control immune stress hematopoiesis - Nature
Neoantigens combined with in situ cancer vaccination induce personalized immunity and reshape the tumor microenvironment - Nature
Immunosuppressive nanoparticles slow atherosclerosis progression in animal models - Phys.org
Immunotherapy
Immunotherapy trial helps cancer patients with tumours live 40% longer - The Guardian
Immunotherapy Drugs Show Major Progress in Early-Stage Cancer - Bloomberg
ASCO: AstraZeneca looks to bring immunotherapy to early-stage stomach cancer with Imfinzi - Fierce Pharma
Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy - Reuters
From No Hope to a Potential Cure for a Deadly Blood Cancer - The New York Times
Immunotherapy plus chemotherapy before lung cancer surgery significantly improves long-term survival, analysis finds - Johns Hopkins University
Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy - Nature
Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers - Yahoo Finance
Avidicure looks to redefine immunotherapy at ASCO 2025 - The Pharma Letter
Immune Deficiency
Causes of a Weak Immune System—and How To Protect Yourself - health.com
Support your immune function with good nutrition - Mayo Clinic Health System
Celeb Hairstylist Jesus Guerrero Cause of Death Revealed as Pneumonia and Fungal Infection, Likely Complications From AIDS - TODAY.com
Granulomatous lymphocytic interstitial lung disease in common variable immune deficiency: an in-depth clinical, immunological, functional and radiological exploration with a focus on its management, challenged by chronic CMV infection - Frontiers
Respiratory Viruses and People with Weakened Immune Systems - Centers for Disease Control and Prevention | CDC (.gov)
U.Va. researchers identify that HIV drugs can protect against Alzheimer’s disease - The Cavalier Daily
Watch Online: A New Documentary About Life With Primary Immunodeficiency - Global Biotechnology Company
Immune Protein Deficiency May Be Key to Type 1 Diabetes Development - University of Missouri School of Medicine
Primary Immune Deficiency Market Size to Reach USD 9.9 Billion by 2035, Impelled by Advancements in Targeted Therapies - BioSpace
Immune system adaptation during gender-affirming testosterone treatment - Nature
AIDS
AIDS/LifeCycle’s final ride: Thousands hit road in Bay Area, ending 3 decades of fundraising - San Francisco Chronicle
Celebrity hairstylist Jesus Guerrero died of pneumonia and fungal infection, likely complications from AIDS - NBC News
Full List of Rite Aid Stores Closing in June - Newsweek
11 stabbed at Salem, Oregon, mission that aids homeless people - CBS News
Rite Aid store closures update: List of doomed locations keeps growing, now includes more than a third of all stores - Fast Company
The U.S. slashed HIV/AIDS funding. Here is how countries that relied on it might adapt - statnews.com
Celeb Hairstylist Jesus Guerrero Cause of Death Revealed as Pneumonia and Fungal Infection, Likely Complications From AIDS - TODAY.com
Hy-Vee aids crews during Wallace’s Garden Center fire - KWQC
The Mouth Tells the Tale: Kaposi Sarcoma as the First Clue to Undiagnosed AIDS - Cureus
Cancer Immunology
Immunotherapy helps Navy veteran beat stage 4 lung cancer - Johns Hopkins University
Old Vaccine, New Tricks: PIE-seq Reveals How BCG Reprograms Immunity - Genetic Engineering and Biotechnology News
Tongue cancer: Immune profiling for improved outcomes - healthcare-in-europe.com
Choi recruited to lead new Center for Cellular Therapies and Cancer Immunology - UT Southwestern Medical Center
Cross-priming in cancer immunology and immunotherapy - Nature
Immunogenomic characteristics and prognostic implications of terminally exhausted CD8+ T cells in colorectal cancers - Frontiers
‘Gift of life’: experts hail neck and head cancer breakthrough - The Guardian
CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers - National Cancer Institute (.gov)
Study reveals hope for immunotherapy as prostate cancer treatment - The University of Arizona Health Sciences
Cancer Immunotherapy Could Get Cheaper, More Widely Available with New Technology | Newswise - Newswise
